Pharmaceutical Contract Manufacturing Company

Formulation Developement  

Formulation Development


Pre-formulation Development


At Dalton Pharma Services we recognize the importance of our clients requirements to develop robust and compliant formulations. Starting with comprehensive pre-formulation services, Dalton helps its customers to determine optimal dosage forms they can use for preclinical or clinical applications. With our analytical development services supporting our preformulation work, Dalton can perform full physico-chemical characterization using modern analytical techniques in-house for rapid turnaround times.

Dalton evaluates and determines a variety of parameters to help you arrive at the right formulation using your API.


These may include:

  • Solubility of API in different media and solvents
  • Excipient compatibility studies
  • Dissolution of the active pharmaceutical ingredient (API)
  • Accelerated Stability Services under various conditions
  • Solid state analysis (polymorphs, particle size, particle shape etc.)

Formulation Development


Dalton brings the right equipment, facilities and highly dedicated formulation specialists to help you arrive at the optimal dosage form for your API and application. We ensure any forms we develop are scalable, compliant and commercializable for our customers.


Dalton Pharma Services, can formulate a wide range of sterile and non-sterile dosage forms including:

  • Oral Immediate Release – Solutions, Emulsions, Suspensions and Capsules
  • Oral Controlled Release – Matrix based release, Multi-particulate systems, Polymer Film Coatings, pH Dependent Release
  • Topical and Transdermals – Gels, Creams, Ointments, Lotions
  • Sterile Liquids – Solutions, Suspensions, Colloids, Liposomes
  • Powders – Sterile and non-sterile powder filling
  • Sterile liquid dosage formulations (ophthalmic, oral, nasal)
  • Injectable drugs (intravenous, and intramuscular, subcutaneous injectables)
  • Lyophilized formulations

Formulation Services and Capabilities

  • Formulation development for new chemical entities (NCE)
  • Optimization of existing formulations
  • Product/Process Optimization
  • Novel formulations for improved delivery of existing dosage forms
  • Controlled release and sustained release formulations
  • Self-emulsifying drug delivery systems
  • Colloidal drug delivery systems
  • Sub-micron and nano-emulsions
  • Feasibility Studies
  • Excipient Compatibility selection and optimization
  • Physico-Chemical Testing
  • Process Scale-Up
  • Technology Transfers
  • Batch manufacture

Home | Company | Services | Products | Resources | News | Careers | Accessibility | Contact